Literature DB >> 20664320

The occurrence of acute myocardial infarction in Italy: a five-year analysis of hospital discharge records.

Prisco Piscitelli1, Giovanni Iolascon, Marco Greco, Alessandra Marinelli, Francesca Gimigliano, Raffaele Gimigliano, Pietro Gisonni, Antonio Giordano, Alberto Migliore, Mauro Granata, Umberto Tarantino, Maria Luisa Brandi, Angelo Baggiani, Alessandro Distante.   

Abstract

BACKGROUND: The incidence and costs of acute myocardial infarction (AMI) in Europe represent a substantial problem due to population aging.
METHODS: Between 2001 and 2005, Italian hospitalization records were examined to evaluate hospital admissions and costs of AMI in adults aged ≥ 45 and in elderly people ≥ 65 or ≥ 75. Hospital costs were calculated on the basis of Diagnosis Related Groups (DRGs).
RESULTS: 75,586 men and 43,164 women were hospitalized because of AMI in 2005, showing respectively increases of 17.2% and 29.2% across five years. In the youngest age group (45-64), 29,925 hospitalizations in men and 6443 in women due to AMI were registered during 2005. In the subgroup of patients aged 65-74, 21,621 men and 10,145 women were hospitalized for AMI; in the oldest group (≥ 75) 24,040 and 26,576 hospitalizations were recorded. The increasing rates across the five examined years were 8.3% and 22.0% in the first age group, 14.3% and 17.4% in people aged 65-74, and 31.8% and 36.3% in the oldest subgroup, respectively in men and women. Among AMI patients aged ≥ 75, the number of women was always higher than that of men. Overall hospitalization costs due to AMI in Italy were 305 million Euros in 2001 and 370 million in 2005, with an average cost of 3115 Euros per patient in the latter year.
CONCLUSION: Our findings confirm AMI as a leading health problem and a leading cause of health care costs.

Entities:  

Mesh:

Year:  2010        PMID: 20664320     DOI: 10.1007/bf03337744

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  4 in total

1.  Lean Management Approach for Reengineering the Hospital Cardiology Consultation Process: A Report from AORN "A. Cardarelli" of Naples.

Authors:  Eduardo Bossone; Massimo Majolo; Serena D'Ambrosio; Eliana Raiola; Michele Sparano; Giuseppe Russo; Giuseppe Longo; Maria Triassi; Angelo Rosa
Journal:  Int J Environ Res Public Health       Date:  2022-04-08       Impact factor: 4.614

2.  Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis.

Authors:  Francesca Pierotti; Ilaria Palla; Maarten Treur; Lara Pippo; Giuseppe Turchetti
Journal:  PLoS One       Date:  2015-10-21       Impact factor: 3.240

3.  Incidence and costs of hip fractures vs strokes and acute myocardial infarction in Italy: comparative analysis based on national hospitalization records.

Authors:  Prisco Piscitelli; Giovanni Iolascon; Alberto Argentiero; Giovanna Chitano; Cosimo Neglia; Gemma Marcucci; Manuela Pulimeno; Marco Benvenuto; Santa Mundi; Valentina Marzo; Daniela Donati; Angelo Baggiani; Alberto Migliore; Mauro Granata; Francesca Gimigliano; Raffaele Di Blasio; Alessandra Gimigliano; Lorenzo Renzulli; Maria Luisa Brandi; Alessandro Distante; Raffaele Gimigliano
Journal:  Clin Interv Aging       Date:  2012-12-17       Impact factor: 4.458

4.  Health technology assessment of belimumab: a new monoclonal antibody for the treatment of systemic lupus erythematosus.

Authors:  Maria Lucia Specchia; Chiara de Waure; Maria Rosaria Gualano; Andrea Doria; Giuseppe Turchetti; Lara Pippo; Francesco Di Nardo; Silvio Capizzi; Chiara Cadeddu; Flavia Kheiraoui; Luca Iaccarino; Francesca Pierotti; Ilaria Palla; Maria Assunta Veneziano; Daniela Gliubizzi; Antonella Sferrazza; Nicola Nicolotti; Rolando Porcasi; Giuseppe La Torre; Maria Luisa Di Pietro; Walter Ricciardi
Journal:  Biomed Res Int       Date:  2014-08-17       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.